57 related articles for article (PubMed ID: 24090809)
21. eEF-2 Phosphorylation Down-Regulates P-Glycoprotein Over-Expression in Rat Brain Microvessel Endothelial Cells.
Tang XH; Wu XY; Xu L; Fang YX; Wang P; Zhu GX; Hong Z
PLoS One; 2015; 10(5):e0125389. PubMed ID: 25962137
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide-activated microglia lower P-glycoprotein function in brain microvascular endothelial cells.
Matsumoto J; Dohgu S; Takata F; Nishioku T; Sumi N; Machida T; Takahashi H; Yamauchi A; Kataoka Y
Neurosci Lett; 2012 Aug; 524(1):45-8. PubMed ID: 22801252
[TBL] [Abstract][Full Text] [Related]
23. Platelet activating factor induces blood brain barrier permeability alteration in vitro.
Fang W; Geng X; Deng Y; Li Y; Shang E; Cen J; Lv P
J Neuroimmunol; 2011 Jan; 230(1-2):42-7. PubMed ID: 20870297
[TBL] [Abstract][Full Text] [Related]
24. [Effect of α-asarone on the Function and Expression of P-glycoprotein in Rat Brain Microvascular Endothelial Cells].
Yuan SY; Sun J; Liu JM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):1-6. PubMed ID: 32131933
[No Abstract] [Full Text] [Related]
25. Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6.
Sun H; Liu XD; Liu Q; Wang FP; Bao XQ; Zhang D
J Asian Nat Prod Res; 2015; 17(6):638-48. PubMed ID: 26235354
[TBL] [Abstract][Full Text] [Related]
26. CJZ3, a lomerizine derivative, modulates P-glycoprotein function in rat brain microvessel endothelial cells.
Ji BS; He L; Li XQ; Liu GQ
Acta Pharmacol Sin; 2006 Apr; 27(4):414-8. PubMed ID: 16539840
[TBL] [Abstract][Full Text] [Related]
27. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption.
Miller DW; Batrakova EV; Waltner TO; Alakhov VYu ; Kabanov AV
Bioconjug Chem; 1997; 8(5):649-57. PubMed ID: 9327127
[TBL] [Abstract][Full Text] [Related]
28. In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier.
Zhang DM; He ZW; Liu XD; Li Y; Xie L; Wang GJ; Liu L
J Pharm Pharmacol; 2007 Dec; 59(12):1733-8. PubMed ID: 18053337
[TBL] [Abstract][Full Text] [Related]
29. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice.
Hamabe W; Maeda T; Fukazawa Y; Kumamoto K; Shang LQ; Yamamoto A; Yamamoto C; Tokuyama S; Kishioka S
Pharmacol Biochem Behav; 2006 Nov; 85(3):629-36. PubMed ID: 17134744
[TBL] [Abstract][Full Text] [Related]
30. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
Varma MV; Sateesh K; Panchagnula R
Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
[TBL] [Abstract][Full Text] [Related]
31. Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier.
Tilloy S; Monnaert V; Fenart L; Bricout H; Cecchelli R; Monflier E
Bioorg Med Chem Lett; 2006 Apr; 16(8):2154-7. PubMed ID: 16464592
[TBL] [Abstract][Full Text] [Related]
32. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
33. Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells.
Zhu HJ; Liu GQ
Acta Pharmacol Sin; 2003 Nov; 24(11):1143-9. PubMed ID: 14627500
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
Zhu X; Sui M; Fan W
Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
[TBL] [Abstract][Full Text] [Related]
35. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
[TBL] [Abstract][Full Text] [Related]
36. Risperidone and paliperidone inhibit p-glycoprotein activity in vitro.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; DeVane CL
Neuropsychopharmacology; 2007 Apr; 32(4):757-64. PubMed ID: 16936711
[TBL] [Abstract][Full Text] [Related]
37. First characterization of fish P-glycoprotein (abcb1) substrate specificity using determinations of its ATPase activity and calcein-AM assay with PLHC-1/dox cell line.
Zaja R; Lončar J; Popovic M; Smital T
Aquat Toxicol; 2011 May; 103(1-2):53-62. PubMed ID: 21392495
[TBL] [Abstract][Full Text] [Related]
38. Nasal delivery of P-gp substrates to the brain through the nose-brain pathway.
Shingaki T; Hidalgo IJ; Furubayashi T; Sakane T; Katsumi H; Yamamoto A; Yamashita S
Drug Metab Pharmacokinet; 2011 Jun; 26(3):248-55. PubMed ID: 21317541
[TBL] [Abstract][Full Text] [Related]
39. Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappaB pathway but not a PI3K/Akt pathway.
Liu H; Yang H; Wang D; Liu Y; Liu X; Li Y; Xie L; Wang G
Eur J Pharmacol; 2009 Jan; 602(2-3):277-82. PubMed ID: 19049803
[TBL] [Abstract][Full Text] [Related]
40. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
